期刊
SCIENCE CHINA-CHEMISTRY
卷 63, 期 6, 页码 766-770出版社
SCIENCE PRESS
DOI: 10.1007/s11426-019-9685-6
关键词
NIR-II; orthotopic osteosarcoma; imaging
资金
- National Natural Science Foundation of China [81773674, 21473041, 81573383]
- Natural Science Foundation of Hubei Province [2017CFB711, 2017CFA024, 2016ACA126]
- Fundamental Research Funds for the Central Universities
- Tibet Autonomous Region Science and Technology Plan Project Key Project [XZ201901-GB-11]
- Applied Basic Research Program of Wuhan Municipal Bureau of Science and Technology [2019020701011429]
- Chengdu University of Traditional Chinese Medicine [CZYJC1903]
- Health Commission of Hubei Province Scientific Research Project [WJ2019M178, WJ2019M177]
Osteosarcoma is the most common primary malignant tumor of bone, particularly among children and adolescents. Advances in imaging, surgical techniques, and implants have dramatically reduced the need for amputation in the past three decades. Recently, in vivo fluorescence imaging in the second near-infrared window (NIR-II, 1,000-1,700 nm) shows impressive advantages of deeper tissue penetration and higher spatial resolution, which makes it a promising tool for the early diagnosis and post-operative observation of Osteosarcoma. To the best of our knowledge, this paper is the first time to develop a novel NIR-II fluorescence probe conjugated with an osteosarcoma targeted oligopeptide for molecular tumor imaging in a xenograft orthotopic osteosarcoma mouse model.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据